Oncology News

Patient and graft survival among liver transplant recipients with hepatocellular carcinoma were poorer with the use of donation after cardiac death allografts in a recent study.

Coffee consumption has been associated with reduced risk for or severity of a variety of liver-related issues, according to a recent systematic review.

Radiofrequency ablation for early or very early hepatocellular carcinoma yielded similar survival rates but was more effective and safer than open resection among older patients in a recent study.

A global phase 3 study of everolimus as a treatment for patients with advanced liver cancer did not improve survival among users compared with placebo recipients, according to a press release.

A global phase 3 study of everolimus as a treatment for patients with advanced liver cancer did not improve survival among users compared with placebo recipients, according to a press release.

Disease-free survival after surgical treatment of hepatitis C-associated hepatocellular carcinoma was significantly influenced by occult or overt hepatitis B coinfection in a recent study.

A new infusion system may allow for the safe and effective treatment of patients with inoperable liver cancer, according to a press release.

Patients with hepatocellular carcinoma and chronic hepatitis C may experience antiviral and antitumoral benefits from treatment with tremelimumab, according to results of a recent pilot study.

Patients with hepatocellular carcinoma and chronic hepatitis C may experience antiviral and antitumoral benefits from treatment with tremelimumab, according to results of a recent pilot study.

Although patients with chronic hepatitis B developed hepatocellular carcinoma at a rate of 1.3 cases per 100 patient-years while receiving antiviral therapy, lamivudine resulted in significantly reduced incidence rates in a recent study.